6-64307042-A-T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001142800.2(EYS):​c.6119T>A​(p.Val2040Asp) variant causes a missense change. The variant allele was found at a frequency of 0.00117 in 1,542,280 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0017 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 12 hom. )

Consequence

EYS
NM_001142800.2 missense

Scores

2
7
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:3B:6

Conservation

PhyloP100: 5.49
Variant links:
Genes affected
EYS (HGNC:21555): (eyes shut homolog) The product of this gene contains multiple epidermal growth factor (EGF)-like and LamG domains. The protein is expressed in the photoreceptor layer of the retina, and the gene is mutated in autosomal recessive retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009310007).
BP6
Variant 6-64307042-A-T is Benign according to our data. Variant chr6-64307042-A-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 137257.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=5, Benign=1, Uncertain_significance=3}. Variant chr6-64307042-A-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.00112 (1556/1390320) while in subpopulation MID AF= 0.0277 (156/5624). AF 95% confidence interval is 0.0242. There are 12 homozygotes in gnomad4_exome. There are 793 alleles in male gnomad4_exome subpopulation. Median coverage is 27. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EYSNM_001142800.2 linkc.6119T>A p.Val2040Asp missense_variant Exon 30 of 43 ENST00000503581.6 NP_001136272.1 Q5T1H1-1
EYSNM_001292009.2 linkc.6119T>A p.Val2040Asp missense_variant Exon 30 of 44 NP_001278938.1 Q5T1H1-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EYSENST00000503581.6 linkc.6119T>A p.Val2040Asp missense_variant Exon 30 of 43 5 NM_001142800.2 ENSP00000424243.1 Q5T1H1-1
EYSENST00000370621.7 linkc.6119T>A p.Val2040Asp missense_variant Exon 30 of 44 1 ENSP00000359655.3 Q5T1H1-3

Frequencies

GnomAD3 genomes
AF:
0.00170
AC:
258
AN:
151842
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000508
Gnomad AMI
AF:
0.00549
Gnomad AMR
AF:
0.00683
Gnomad ASJ
AF:
0.00605
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000624
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.00112
Gnomad OTH
AF:
0.00817
GnomAD3 exomes
AF:
0.00171
AC:
262
AN:
152886
Hom.:
1
AF XY:
0.00167
AC XY:
136
AN XY:
81226
show subpopulations
Gnomad AFR exome
AF:
0.000254
Gnomad AMR exome
AF:
0.00377
Gnomad ASJ exome
AF:
0.00542
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00141
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00113
Gnomad OTH exome
AF:
0.00536
GnomAD4 exome
AF:
0.00112
AC:
1556
AN:
1390320
Hom.:
12
Cov.:
27
AF XY:
0.00116
AC XY:
793
AN XY:
686318
show subpopulations
Gnomad4 AFR exome
AF:
0.000797
Gnomad4 AMR exome
AF:
0.00346
Gnomad4 ASJ exome
AF:
0.00510
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00125
Gnomad4 FIN exome
AF:
0.0000205
Gnomad4 NFE exome
AF:
0.000810
Gnomad4 OTH exome
AF:
0.00270
GnomAD4 genome
AF:
0.00168
AC:
256
AN:
151960
Hom.:
1
Cov.:
32
AF XY:
0.00194
AC XY:
144
AN XY:
74276
show subpopulations
Gnomad4 AFR
AF:
0.000506
Gnomad4 AMR
AF:
0.00682
Gnomad4 ASJ
AF:
0.00605
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000624
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00112
Gnomad4 OTH
AF:
0.00808
Alfa
AF:
0.00192
Hom.:
0
Bravo
AF:
0.00232
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000519
AC:
2
ExAC
AF:
0.00180
AC:
38
Asia WGS
AF:
0.000867
AC:
3
AN:
3474

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:3Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:3
Dec 16, 2011
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jun 17, 2014
Eurofins Ntd Llc (ga)
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 15, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: EYS c.6119T>A (p.Val2040Asp) results in a non-conservative amino acid change located in the first laminin G repeat domain (IPR001791) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0017 in 152886 control chromosomes, predominantly at a frequency of 0.0038 within the Latino subpopulation in the gnomAD database. The observed variant frequency within Latino control individuals in the gnomAD database is approximately 1.11 fold of the estimated maximal expected allele frequency for a pathogenic variant in EYS causing Retinitis Pigmentosa phenotype (0.0034), strongly suggesting that the variant is a benign polymorphism. c.6119T>A has been reported in the literature in individuals affected with Retinitis Pigmentosa (Audo_2010, Barragan_2010, Sharon_2020, Dinero_2020). These reports do not provide unequivocal conclusions about association of the variant with Retinitis Pigmentosa. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Five other ClinVar submitters have assessed the variant since 2014: two classified the variant as of uncertain significance, two as likely benign, and one as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely benign. -

Retinitis pigmentosa Pathogenic:1Uncertain:1
Jun 23, 2019
Sharon lab, Hadassah-Hebrew University Medical Center
Significance: Likely pathogenic
Review Status: no assertion criteria provided
Collection Method: research

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Retinitis pigmentosa 25 Uncertain:1Benign:1
May 18, 2021
Pars Genome Lab
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 11, 2019
Baylor Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

not provided Benign:2
Jan 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

EYS: BP4 -

Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Retinal dystrophy Uncertain:1
Jan 01, 2023
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.73
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.042
.;T
Eigen
Uncertain
0.27
Eigen_PC
Uncertain
0.32
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.59
T;T
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.0093
T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
0.34
N;N
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.91
N;N
REVEL
Uncertain
0.30
Sift
Uncertain
0.0010
D;T
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
D;D
Vest4
0.42
MVP
0.66
MPC
0.058
ClinPred
0.036
T
GERP RS
5.1
Varity_R
0.38
gMVP
0.17

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201580493; hg19: chr6-65016935; COSMIC: COSV65520896; API